X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
r-chop (692) 692
index medicus (529) 529
humans (513) 513
oncology (419) 419
rituximab (389) 389
male (376) 376
female (364) 364
aged (360) 360
middle aged (351) 351
chemotherapy (341) 341
hematology (338) 338
lymphoma, large b-cell, diffuse - drug therapy (291) 291
prognosis (284) 284
antineoplastic combined chemotherapy protocols - therapeutic use (280) 280
lymphomas (277) 277
adult (266) 266
elderly-patients (261) 261
non-hodgkins-lymphoma (252) 252
diffuse large b-cell lymphoma (234) 234
aged, 80 and over (226) 226
survival (193) 193
cancer (185) 185
treatment outcome (185) 185
lymphoma, large b-cell, diffuse - mortality (176) 176
doxorubicin - administration & dosage (159) 159
cyclophosphamide - administration & dosage (156) 156
vincristine - administration & dosage (155) 155
lymphoma, large b-cell, diffuse - pathology (149) 149
young adult (139) 139
prednisone - administration & dosage (136) 136
retrospective studies (136) 136
antineoplastic combined chemotherapy protocols - administration & dosage (134) 134
cyclophosphamide (133) 133
b-cell lymphoma (127) 127
lymphoma (127) 127
cyclophosphamide - therapeutic use (119) 119
vincristine - therapeutic use (118) 118
doxorubicin - therapeutic use (117) 117
prednisone - therapeutic use (114) 114
care and treatment (111) 111
disease-free survival (111) 111
lymphoma, large b-cell, diffuse - diagnosis (106) 106
dlbcl (105) 105
adolescent (104) 104
chemotherapy plus rituximab (103) 103
antibodies, monoclonal, murine-derived - administration & dosage (101) 101
hemic and lymphatic diseases (98) 98
antibodies, monoclonal, murine-derived - therapeutic use (97) 97
vincristine (92) 92
analysis (91) 91
doxorubicin (89) 89
immunohistochemistry (88) 88
medicine & public health (86) 86
neoplasm staging (86) 86
lymphoma, large b-cell, diffuse - genetics (84) 84
antibodies, monoclonal, murine-derived (83) 83
survival analysis (83) 83
antineoplastic combined chemotherapy protocols - adverse effects (77) 77
kaplan-meier estimate (74) 74
therapy (72) 72
trial (71) 71
immune system diseases (66) 66
classification (65) 65
diffuse large b cell lymphoma (64) 64
expression (64) 64
follow-up studies (64) 64
prednisone (64) 64
follicular lymphoma (63) 63
risk factors (63) 63
survival rate (60) 60
anthracyclines (59) 59
lymphocytes b (59) 59
doxorubicin - adverse effects (58) 58
lymphoma, large b-cell, diffuse - therapy (58) 58
patients (58) 58
cyclophosphamide - adverse effects (57) 57
randomized controlled-trial (57) 57
vincristine - adverse effects (57) 57
phase-ii (56) 56
lymphoma, large b-cell, diffuse - metabolism (55) 55
non-hodgkin-lymphoma (55) 55
chop chemotherapy (52) 52
multivariate analysis (52) 52
transplantation (52) 52
gene expression (51) 51
prednisone - adverse effects (51) 51
antimitotic agents (49) 49
antineoplastic agents (49) 49
corticosteroids (49) 49
medical prognosis (47) 47
antibodies, monoclonal - administration & dosage (46) 46
prognostic-significance (46) 46
antineoplastic agents - therapeutic use (45) 45
elderly (45) 45
gene-expression (45) 45
protein expression (45) 45
research (45) 45
rituximab - administration & dosage (45) 45
antibodies, monoclonal, murine-derived - adverse effects (44) 44
chop (44) 44
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (749) 749
Japanese (21) 21
French (4) 4
German (4) 4
Russian (4) 4
Korean (2) 2
Hungarian (1) 1
Indonesian (1) 1
Serbian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The Lancet Oncology, ISSN 1470-2045, 08/2017, Volume 18, Issue 8, pp. 1076 - 1088
The prognosis of young patients with diffuse large B-cell lymphoma at high risk (age-adjusted International Prognostic Index [aa-IPI] score 2 or 3) treated... 
CLINICAL-PRACTICE GUIDELINES | SURVIVAL | SUPPORT | IMPACT | CONSOLIDATION | RESPONSE CRITERIA | ONCOLOGY | R-CHOP | NON-HODGKIN-LYMPHOMA | ELDERLY-PATIENTS | MEGACHOEP | Cyclophosphamide - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Follow-Up Studies | Mitoxantrone - administration & dosage | Humans | Middle Aged | Antibodies, Monoclonal, Murine-Derived - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Induction Chemotherapy | Male | Transplantation, Autologous | Consolidation Chemotherapy | Cyclophosphamide - adverse effects | Lymphoma, Large B-Cell, Diffuse - therapy | Vincristine - administration & dosage | Adult | Female | Doxorubicin - administration & dosage | Hematologic Diseases - chemically induced | Prednisone - administration & dosage | Dexamethasone - administration & dosage | Prednisone - adverse effects | Risk Factors | Etoposide - administration & dosage | Survival Rate | Cytarabine - administration & dosage | Rituximab - administration & dosage | Disease-Free Survival | Melphalan - administration & dosage | Intention to Treat Analysis | Vincristine - adverse effects | Antibodies, Monoclonal, Murine-Derived - adverse effects | Doxorubicin - adverse effects | Carmustine - administration & dosage | Stem Cell Transplantation - adverse effects | Stem cells
Journal Article
Journal Article
Leukemia, ISSN 0887-6924, 12/2011, Volume 25, Issue 12, pp. 1877 - 1881
Journal Article
Blood, ISSN 0006-4971, 12/2010, Volume 116, Issue 24, pp. 5119 - 5125
Journal Article
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 08/2017, Volume 35, Issue 22, pp. 2473 - 2481
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 12/2012, Volume 30, Issue 36, pp. 4462 - 4469
Journal Article
American Journal of Hematology, ISSN 0361-8609, 11/2016, Volume 91, Issue 11, pp. 1113 - 1117
Journal Article
Journal Article
American Journal of Hematology, ISSN 0361-8609, 12/2013, Volume 88, Issue 12, pp. 1062 - 1067
Journal Article
International Journal of Hematology, ISSN 0925-5710, 6/2016, Volume 103, Issue 6, pp. 676 - 685
Journal Article